Zimmer Biomet Holdings Inc. reported a 9.3% year-on-year revenue increase, reaching $2.09 billion, amidst news of Biomet, Inc.'s impending $10.9 billion acquisition by a private equity consortium at $44 per share. This financial performance coincided with a slight rise in Zimmer Biomet's stock price, now at $83.70, reflecting shifting dynamics in the healthcare market as the company positions itself for future growth.
Loading timeline…
.svg&width=160)